Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free MBX Stock Alerts

Microbix Biosystems (MBX) Competitors

Microbix Biosystems logo
C$0.30 0.00 (0.00%)
As of 07/3/2026 11:08 AM Eastern
Compare

MBX vs. IPA, HBP, SCYB, COM, and NVH

Should you buy Microbix Biosystems stock or one of its competitors? MarketBeat compares Microbix Biosystems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbix Biosystems include ImmunoPrecise Antibodies (IPA), Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), and Novoheart (NVH). These companies are all part of the "biotechnology" industry.

How does Microbix Biosystems compare to ImmunoPrecise Antibodies?

Microbix Biosystems (TSE:MBX) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Microbix Biosystems has higher earnings, but lower revenue than ImmunoPrecise Antibodies. Microbix Biosystems is trading at a lower price-to-earnings ratio than ImmunoPrecise Antibodies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
ImmunoPrecise AntibodiesC$19.47M8.33-C$22.19M-C$0.89N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than ImmunoPrecise Antibodies. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for ImmunoPrecise Antibodies. Microbix Biosystems' average media sentiment score of 1.00 beat ImmunoPrecise Antibodies' score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the media.

Company Overall Sentiment
Microbix Biosystems Positive
ImmunoPrecise Antibodies Neutral

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

ImmunoPrecise Antibodies has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. ImmunoPrecise Antibodies' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
ImmunoPrecise Antibodies N/A N/A N/A

Summary

Microbix Biosystems beats ImmunoPrecise Antibodies on 7 of the 12 factors compared between the two stocks.

How does Microbix Biosystems compare to Helix BioPharma?

Helix BioPharma (TSE:HBP) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Microbix Biosystems has higher revenue and earnings than Helix BioPharma. Helix BioPharma is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helix BioPharmaN/AN/A-C$50.55M-C$0.04N/A
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A

Helix BioPharma has a beta of 0.421776, meaning that its share price is 58% less volatile than the broader market. Comparatively, Microbix Biosystems has a beta of 0.675979, meaning that its share price is 32% less volatile than the broader market.

0.0% of Helix BioPharma shares are owned by institutional investors. Comparatively, 0.2% of Microbix Biosystems shares are owned by institutional investors. 2.2% of Helix BioPharma shares are owned by company insiders. Comparatively, 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Helix BioPharma and Helix BioPharma both had 1 articles in the media. Helix BioPharma's average media sentiment score of 1.38 beat Microbix Biosystems' score of 1.00 indicating that Helix BioPharma is being referred to more favorably in the media.

Company Overall Sentiment
Helix BioPharma Positive
Microbix Biosystems Positive

Helix BioPharma has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Microbix Biosystems' return on equity of -21.02% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Helix BioPharmaN/A -21.54% -279.98%
Microbix Biosystems -38.62%-21.02%3.82%

Summary

Microbix Biosystems beats Helix BioPharma on 8 of the 11 factors compared between the two stocks.

How does Microbix Biosystems compare to Scythian Biosciences?

Scythian Biosciences (CVE:SCYB) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

Scythian Biosciences has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Scythian Biosciences' return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Scythian BiosciencesN/A N/A N/A
Microbix Biosystems -38.62%-21.02%3.82%

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Microbix Biosystems has higher revenue and earnings than Scythian Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scythian BiosciencesN/AN/AN/AN/AN/A
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than Scythian Biosciences. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Scythian Biosciences. Microbix Biosystems' average media sentiment score of 1.00 beat Scythian Biosciences' score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
Scythian Biosciences Neutral
Microbix Biosystems Positive

Summary

Microbix Biosystems beats Scythian Biosciences on 6 of the 8 factors compared between the two stocks.

How does Microbix Biosystems compare to 138267 (COM.TO)?

138267 (COM.TO) (TSE:COM) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

138267 (COM.TO) has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. 138267 (COM.TO)'s return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
138267 (COM.TO)N/A N/A N/A
Microbix Biosystems -38.62%-21.02%3.82%

0.2% of Microbix Biosystems shares are held by institutional investors. 14.0% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Microbix Biosystems had 1 more articles in the media than 138267 (COM.TO). MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for 138267 (COM.TO). Microbix Biosystems' average media sentiment score of 1.00 beat 138267 (COM.TO)'s score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
138267 (COM.TO) Neutral
Microbix Biosystems Positive

Microbix Biosystems has higher revenue and earnings than 138267 (COM.TO).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A

Summary

Microbix Biosystems beats 138267 (COM.TO) on 6 of the 8 factors compared between the two stocks.

How does Microbix Biosystems compare to Novoheart?

Microbix Biosystems (TSE:MBX) and Novoheart (CVE:NVH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.

Microbix Biosystems has higher revenue and earnings than Novoheart. Novoheart is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$14.81M2.78C$3.39M-C$0.04N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

In the previous week, Microbix Biosystems had 1 more articles in the media than Novoheart. MarketBeat recorded 1 mentions for Microbix Biosystems and 0 mentions for Novoheart. Microbix Biosystems' average media sentiment score of 1.00 beat Novoheart's score of 0.00 indicating that Microbix Biosystems is being referred to more favorably in the media.

Company Overall Sentiment
Microbix Biosystems Positive
Novoheart Neutral

0.2% of Microbix Biosystems shares are owned by institutional investors. 14.0% of Microbix Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Novoheart has a net margin of 0.00% compared to Microbix Biosystems' net margin of -38.62%. Novoheart's return on equity of 0.00% beat Microbix Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems-38.62% -21.02% 3.82%
Novoheart N/A N/A N/A

Summary

Microbix Biosystems beats Novoheart on 8 of the 12 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

Export
MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$41.25MC$516.65MC$7.18BC$13.07B
Dividend Yield2.30%3.88%2.66%6.18%
P/E Ratio-7.323.0928.0236.51
Price / Sales2.786,669.11535.3610.34
Price / Cash4.1313.1349.2682.29
Price / Book1.6588.6710.964.52
Net IncomeC$3.39M-C$96.07MC$3.57BC$299.09M
7 Day Performance1.69%0.17%2.12%1.85%
1 Month Performance11.11%2.10%5.25%1.71%
1 Year PerformanceN/A68.02%33.29%36.40%

Microbix Biosystems Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBX
Microbix Biosystems
N/AC$0.30
flat		N/A+0.0%C$41.25MC$14.81MN/AN/A
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%		N/A+0.0%C$162.08MC$19.47MN/A80
HBP
Helix BioPharma
N/AC$1.37
flat		N/A+44.3%C$104.64MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:MBX) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel